Immunoregulatory Compounds and Derivatives and methods of treating diseases therewith
Details for Australian Patent Application No. 2005244526 (hide)
International Classifications
Event Publications
12 January 2006 Application Open to Public Inspection
Published as AU-B-2005244526
12 January 2006 Complete Application Filed
20 July 2006 Assignment before Grant
Nobex Corporation The application has been assigned to Biocon, Ltd 2006
10 September 2009 Application Accepted
Published as AU-B-2005244526
24 September 2009 Application for Amendment
The nature of the amendment is: Amend the name of the inventor to read from Elwuribe, Nnochiri N. to Ekwuribe, Nnochiri N.. Address for service in Australia - Watermark Patent & Trademark Attorneys 302 Burwood Road Hawthorn VIC 3122
14 January 2010 Amendment Made
The nature of the amendment is: Amend the name of the inventor to read from Elwuribe, Nnochiri N. to Ekwuribe, Nnochiri N.
21 January 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005244525-Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser